Showing results (2111-2120 of 2,507) with videos related to
Sort By:
Pageof 251
Nature Genetics|September 5, 2017
Reconstruction of enhancer-target networks in 935 samples of human primary cells, tissues and cell linesQin Cao, Christine Anyansi, Xihao Hu, et al.Neuroscience|March 22, 2018
Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERKT H Wang, S Y Wang, X D Wang, et al.Comprehensive Child and Adolescent Nursing|January 15, 2019
Knowledge and Perceptions of Child Protection and Mandatory Reporting: A Survey of Nurses in Hong KongA C Y Chan, W L Cheng, Y N Lin, et al.Molecular Cancer Research : MCR|September 3, 2025
Cancer genomic alterations and microenvironmental features encode synergistic interactions with disease outcomesMasroor Bayati, Zoe P Klein, Alexander T Bahcheli, et al.British Journal of Cancer|June 29, 2006
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancerY Chao, C P Li, T Y Chao, et al.British Journal of Cancer|February 18, 2010
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinomaC-H Hsu, T-S Yang, C Hsu, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 18, 2009
Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysisJ-L Liu, F-Y Zhang, Y-H Liang, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 17, 2014
Activated protein C (APC) can increase bone anabolism via a protease-activated receptor (PAR)1/2 dependent mechanismKaitlin Shen, Ciara M Murphy, Ben Chan, et al.Proceedings. Biological Sciences|December 5, 2014
Host and pathogen ecology drive the seasonal dynamics of a fungal disease, white-nose syndromeKate E Langwig, Winifred F Frick, Rick Reynolds, et al.British Journal of Cancer|March 17, 2005
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancerK H Yeh, Y S Lu, C H Hsu, et al.Pageof 251